Gohealth, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
GOCO
Gohealth, INCGoHealth, Inc. reported a significant net loss and substantial impairment charges for Q3 2025, driven by a strategic pullback in Medicare Advantage activity and tightening health plan economics, raising substantial doubt about its ability to continue as a going concern.
NASDAQ
GOCO
Gohealth, INCGoHealth, Inc. reported increased net losses for Q2 2025 and H1 2025, alongside a significant intangible asset impairment, but secured new financing and debt amendments to alleviate going concern doubts.
NASDAQ
GOCO
Gohealth, INCGoHealth, Inc. announced its Q1 2025 financial results, showcasing revenue growth but also raising concerns about its ability to continue as a going concern due to potential covenant compliance issues.
NASDAQ
GOCO
Gohealth, INC10-Q: GoHealth Reports Q3 2024 Results, Includes Gain on Bargain Purchase from e-TeleQuote Acquisition
GoHealth's Q3 2024 results show a net income of $15.4 million, which includes a significant gain from the acquisition of e-TeleQuote Insurance, Inc.
NASDAQ
GOCO
Gohealth, INCGoHealth's second quarter 2024 results show a decrease in revenue and a net loss, as the company continues its strategic shift towards a Medicare engagement model.
NASDAQ
GOCO
Gohealth, INCGoHealth's first quarter of 2024 saw a slight revenue increase alongside a strategic shift towards a Medicare engagement model, impacting both agency and non-agency revenue streams.